(11-086) Analysis of the Safety and Efficacy of Low vs Standard-Dose 4-Factor Prothrombin Complex Concentrate Anticoagulation Reversal for Patients on Apixaban or Rivaroxaban
Wednesday, December 11, 2024
12:30 PM – 1:30 PM
Location: Hall G, Lower Level
Category: Research-in-Progress Topic: Critical Care